MISSISSAUGA, ON, Jan. 18 /CNW/ - YM BioSciences Inc. (AMEX:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has been notified that Accipiter Life Sciences Fund, LP and affiliated funds now hold 3,497,795 Common Shares in the Company.
